Trial · NCT01652573
Results by group36
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 36
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Area Under the Curve for FGF23 | Nasal Calictonin | 3172.34 | 95% Confidence Interval 3068.7 to 3332.68 | pg/ml*hr | |
| Area Under the Curve for FGF23 | Saline Nasal Spray | 3215.34 | 95% Confidence Interval 3107.17 to 3374.97 | pg/ml*hr | |
| Area Under the Curve for FGF23 | Nasal Calictonin | 2698.38 | 95% Confidence Interval 2623.07 to 2830.39 | pg/ml*hr | |
| Area Under the Curve for FGF23 | Saline Nasal Spray | 2994.26 | 95% Confidence Interval 2907.61 to 3134.26 | pg/ml*hr | |
| Area Under the Curve for TmP/GFR | Nasal Calictonin | 30.70 | 95% Confidence Interval 29.5 to 32.27 | mg/100 ml GF*hr | |
| Area Under the Curve for TmP/GFR | Saline Nasal Spray | 29.97 | 95% Confidence Interval 28.78 to 31.49 | mg/100 ml GF*hr | |
| Area Under the Curve for 1,25(OH)2vitamin D | Nasal Calictonin | 904.06 | 95% Confidence Interval 862.86 to 961.90 | ng/ml*hr | |
| Area Under the Curve for 1,25(OH)2vitamin D | Saline Nasal Spray | 838.58 | 95% Confidence Interval 799.18 to 892.99 | ng/ml*hr | |
| Number of Patients With Nasal Congestion at Baseline | Nasal Calictonin | 0 | Participants | ||
| Number of Patients With Nasal Congestion at Baseline | Saline Nasal Spray | 0 | Participants | ||
| Area Under the Curve for TmP/GFR | Nasal Calictonin | 32.17 | 95% Confidence Interval 31.04 to 33.68 | mg/100 ml GF*hr | |
| Area Under the Curve for TmP/GFR | Saline Nasal Spray | 31.26 | 95% Confidence Interval 30.13 to 32.74 | mg/100 ml GF*hr | |
| Area Under the Curve for 1,25(OH)2vitamin D | Nasal Calictonin | 1277.05 | 95% Confidence Interval 1235.72 to 1335.02 | ng/ml*hr | |
| Area Under the Curve for 1,25(OH)2vitamin D | Saline Nasal Spray | 1258.84 | 95% Confidence Interval 1217.74 to 1315.70 | ng/ml*hr | |
| Number of Participants With Nasal Congestion at 1 Month | Nasal Calictonin | 3 | Participants | ||
| Number of Participants With Nasal Congestion at 1 Month | Saline Nasal Spray | 2 | Participants | ||
| Number of Participants With Nasal Congestion at 2 Months | Nasal Calictonin | 1 | Participants | ||
| Number of Participants With Nasal Congestion at 2 Months | Saline Nasal Spray | 0 | Participants | ||
| Number of Participants With Nasal Congestion at 3 Months | Nasal Calictonin | 0 | Participants | ||
| Number of Participants With Nasal Congestion at 3 Months | Saline Nasal Spray | 0 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01652573/results